Relative toxicity of benzodiazepines and hypnotics commonly used for self-poisoning: An epidemiological study of fatal toxicity and case fatality

Abstract

The relative toxicity of anxiolytic and hypnotic drugs commonly used for self-poisoning was assessed using data on suicides, prescriptions and non-fatal self-poisonings in England, 2005–2012. Data on suicide by self-poisoning were obtained from the Office for National Statistics, information on intentional non-fatal self-poisoning was derived from the Multicentre Study of Self-harm in England and data on prescriptions in general practice from the Clinical Practice Research Datalink. We used two indices of relative toxicity: fatal toxicity (the number of fatal self-poisonings relative to the number of individuals prescribed each drug) and case fatality (the number of fatal relative to non-fatal self-poisonings). Diazepam was the reference drug in all analyses. Temazepam was 10 times (95% confidence interval 5.48–18.99) and zopiclone/zolpidem nine times (95% confidence interval 5.01–16.65) more toxic in overdose than diazepam (fatal-toxicity index). Temazepam and zopiclone/zolpidem were 13 (95% confidence interval 6.97–24.41) and 12 (95% confidence interval 6.62–22.17) times more toxic than diazepam, respectively (case-fatality index). Differences in alcohol involvement between the drugs were unlikely to account for the findings. Overdoses of temazepam and zopiclone/zolpidem are considerably more likely to result in death than overdoses of diazepam. Practitioners need to exercise caution when prescribing these drugs, especially for individuals who may be at risk of self-harm, and also consider non-pharmacological options.

Keywords

Minor tranquilisers sedatives relative toxicity suicide self-harm self-poisoning

Get full access to this article

View all access options for this article.

References

Alessi-Severini

Bolton

Enns

et al . (2014) Use of benzodiazepines and related drugs in Manitoba: A population-based study. CMAJ Open 2: E208–E216.

Alexander

Perry

(1991) Detoxification from benzodiazepines: Schedules and strategies. J Subst Abuse Treat 8: 9–17.

Bjornaas

Teige

Hovda

et al . (2010) Fatal poisonings in Oslo: A one-year observational study. BMC Emerg Med 10: 13.

Bjorngaard

Bjerkeset

Romundstad

et al . (2011) Sleeping problems and suicide in 75,000 Norwegian adults: A 20 year follow-up of the HUNT I study. Sleep 34: 1155–1159.

British National Formulary (2014) Changes in the Legal Classification of Tramadol, Lisdexamfetamine, Zaleplon, and Zopiclone. Available at: http://www.pharmpress.com/mailouts/bnf/jun14/BNF_enewsletter.html.

British National Formulary (2017) Controlled Drugs and Drug Dependence. Available at: https://www.medicinescomplete.com/mc/bnf/current/PHP97239-controlled-drugs-and-drug-dependence.htm?q=temazepam%20prescription&t=search&ss=text&tot=2&p=1#_hit.

Buckley

Dawson

Whyte

et al . (1995) Relative toxicity of benzodiazepines in overdose. BMJ 310: 219–221.

Buckley

McManus

(2004) Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983–1999). Drug Saf 27: 135–141.

Camidge

Wood

Bateman

(2003) The epidemiology of self-poisoning in the UK. Br J Clin Pharmacol 56: 613–619.

10.

Department for Communities and Local Government (2008) The English Indices of Deprivation 2007. Available at: http://geoconvert.mimas.ac.uk/help/imd-2007-manual.pdf.

11.

Geulayov

Kapur

Turnbull

et al . (2016) Epidemiology and trends in non-fatal self-harm in three centres in England, 2000–2012: Findings from the Multicentre Study of Self-harm in England. BMJ Open 6: e010538.

12.

Gibson

(2004) Newer hypnotics no better for insomnia than short acting benzodiazepines. BMJ 328: 1093.

13.

Gobbi

Barone

Mennini

et al . (1987) Diazepam and desmethyldiazepam differ in their affinities and efficacies at ‘central’ and ‘peripheral’ benzodiazepine receptors. J Pharm Pharmacol 39: 388–391.

14.

Gunnell

Bennewith

Simkin

et al . (2013) Time trends in coroners’ use of different verdicts for possible suicides and their impact on officially reported incidence of suicide in England: 1990–2005. Psychol Med 43: 1415–1422.

15.

Hawton

(2007) Restricting access to methods of suicide: Rationale and evaluation of this approach to suicide prevention. Crisis 28(Suppl 1): 4–9.

16.

Hawton

Bergen

Casey

et al . (2007) Self-harm in England: A tale of three cities. Multicentre study of self-harm. Soc Psychiatry Psychiatr Epidemiol 42: 513–521.

17.

Hawton

Harriss

Hall

et al . (2003) Deliberate self-harm in Oxford, 1990–2000: A time of change in patient characteristics. Psychol Med 33: 987–996.

18.

Hawton

Saunders

Topiwala

et al . (2013) Psychiatric disorders in patients presenting to hospital following self-harm: A systematic review. J Affect Disord 151: 821–830.

19.

Herrett

Gallagher

Bhaskaran

et al . (2015) Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 44: 827–836.

20.

Hysing

Sivertsen

Stormark

et al . (2015) Sleep problems and self-harm in adolescence. Br J Psychiatry 207: 306–312.

21.

Khan

Leventhal

Khan

et al . (2002) Suicide risk in patients with anxiety disorders: A meta-analysis of the FDA database. J Affect Disord 68: 183–190.

22.

Koski

Ojanpera

Vuori

(2002) Alcohol and benzodiazepines in fatal poisonings. Alcohol Clin Exp Res 26: 956–959.

23.

Linsley

Schapira

Kelly

(2001) Open verdict v. suicide - importance to research. Br J Psychiatry 178: 465–468.

24.

Mendelson

Rich

(1993) Sedatives and suicide: The San Diego study. Acta Psychiatr Scand 88: 337–341.

25.

Mitchell

Gehrman

Perlis

et al . (2012) Comparative effectiveness of cognitive behavioral therapy for insomnia: A systematic review. BMC Fam Pract 13: 40.

26.

Muller

Stillbauer

(1983) Benzodiazepine hypnotics: Time course and potency of benzodiazepine receptor occupation after oral application. Pharmacol Biochem Behav 18: 545–549.

27.

National Institute for Health and Care Excellence (2004) Guidance on the use of Zaleplone, Zolpidem and Zopiclone for the Short-term Management of Insomnia. Available at: https://www.nice.org.uk/guidance/ta77/resources/guidance-on-the-use-of-zaleplon-zolpidem-and-zopiclone-for-the-shortterm-management-of-insomnia-2294763557317.

28.

National Institute for Health and Care Excellence (2014) Eyes on Evidence : Prescriptions for Anxiolytics and Hypnotics and Risk of Death. Available at: https://www.evidence.nhs.uk/search?q=Prescriptions+for+anxiolytics+and+hypnotics+and+risk+of+death.

29.

Newcombe

(2009) Zopiclone: Assessment of the Consumption and Consequences of Zopiclone (Zimovane) Among Drug-takers in a North-East Town. Available at: http://www.addictioneduhourcation.co.uk/zopiclone-report-sep09.pd

30.

NHS Business Services Authority (2012) Hypnotic Drugs. Available at: http://www.nhsbsa.nhs.uk/searchpage.aspx?terms=hypnotics.

31.

NHS Digital (2015) Prescriptions Dispensed in the Community, Statistics for England - 2004–2014. London: NHS Digital.

32.

NHS Digital (2016) Prescriptions Dispensed in the Community England 2005-2015. London: NHS Digital. Available at: https://digital.nhs.uk/catalogue/PUB20664.

33.

Office for National Statistics (2014) Deaths Related to Drug Poisoning in England and Wales, 2013. Available at: http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/dcp171778_375498.pdf.

34.

Office for National Statistics (2015) Statistical Update on Suicide. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/405411/Statistical_update_on_suicide_acc.pdf.

35.

Office for National Statistics (2016) Population Estimates for UK, England and Wales, Scotland and Northern Ireland. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland.

36.

Perlis

Grandner

Brown

et al . (2016) Nocturnal wakefulness as a previously unrecognized risk factor for suicide. J Clin Psychiatry 77: e726–e733.

37.

Reith

Fountain

McDowell

et al . (2003) Comparison of the fatal toxicity index of zopiclone with benzodiazepines. J Toxicol Clin Toxicol 41: 975–980.

38.

Serfaty

Masterton

(1993) Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 163: 386–393.

39.

Siebern

Suh

Nowakowski

(2012) Non-pharmacological treatment of insomnia. Neurotherapeutics 9: 717–727.

40.

The Clinical Practice Research Datalink (2016) The Clinical Practice Research Datalink. Available at: https://www.cprd.com/Home/.

41.

The Goverment of Western Australia - Department of Health (2013) Storage and Recording of Restricted Schedule 4 (S4R) Medicines. Available at: http://www.health.wa.gov.au/circularsnew/attachments/900.pdf.

42.

Weich

Pearce

Croft

et al . (2014) Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: Retrospective cohort study. BMJ 348: g1996.

43.

World Health Organization (2006) Essential Medicines and Health Products: Assessment of Zopiclone. Available at: http://www.who.int/medicines/areas/quality_safety/34thecddmeet/en/.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB